Prostate cancer: Three-in-one blood test could fuel personalized treatment

A single blood test could identify how prostate cancer patients will respond to PARP inhibitors in as little as 4 to 8 weeks, say researchers.

Be the first to comment

Leave a Reply

Your email address will not be published.


*